Affiliation:
1. Jawaharlal Nehru Institute of Medical Sciences, Imphal, Manipur, India
Abstract
: A malignant tumor of immature T cells, T-cell acute lymphoblastic leukemia/lymphoma is known by this acronym, T-ALL. 12-15% percent of all cases of acute leukemia are T-ALL. According to the 2017 WHO classification, early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL) is a unique and uncommon condition. It includes 17–22% of adult T-ALL cases and 12–16.2% of childhood T-ALL cases.: To examine the immunophenotypic and clinicohematologic features of T-ALL.: A retrospective analysis was conducted on all acute leukemia diagnoses made in the Pathology Department, Jawaharlal Nehru Institute of Medical Sciences, Imphal between June 2020 and June 2023, a period of three years. After completing all required tests, such as a CBC and a bone marrow examination, flow cytometric immunophenotyping was performed either from peripheral blood or the bone marrow aspirate. For immunophenotyping, a 11 color flowcytometer (BECKMAN COULTER) was utilized. Markers for T cell lymphoid lineage included CD3, CD5, CD4, CD7, CD8, and cCd3 while markers for B cell lineage included CD19, CD20, CD22, CD10 and cCD79a. Regarding the myeloid markers, CD117, CD13,CD38, and Myeloperoxidase ; the immaturity markers such as CD 34 and HLA-DR; and the monocytic markers CD33, CD14, CD64 and CD11c were used. ETP-ALL diagnosis was accomplished using specific scoring systems.: Out of the 150 acute leukemia cases that were diagnosed during this time, 15 (10%) were categorized as T-ALL according to WHO guidelines. Median age was calculated as 17 (range: 4–60 years). 11/15 (73.3%) of the cases were male, and 4/15 (26.6%) were female. Of the 4 female cases, 2 were found to have ETP-ALL. This study was carried out since there is a dearth of data from this region of the nation. Furthermore, because ETP-ALL cases have a bad prognosis, it is important to get a thorough diagnosis.
Publisher
IP Innovative Publication Pvt Ltd
Reference21 articles.
1. Gupta R, Garg N, Kotru M, Kumar D, Pathak R, Immunophenotypic characteristics of T lineage acute lymphoblastic leukemia: absence of immaturity markers-TdT, CD34 and HLADR is not uncommon.Am J Blood Res 2022;12(1):1-10
2. Gorczyca W, Weisberger J, Liu Z, Tsang P, Hossein M, Wu CD, An approach to diagnosis of T-cell lymphoproliferative disorders by flow cytometry.Cytometry 2002;50(3):177-90
3. Faber J, Kantarjian H, Roberts WM, Keating M, Freireich E, Albitar M, Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.Arch Pathol Lab Med 2000;124(1):92-7
4. Ross CW, Stoolman LM, Schnitzer B, Schlegelmilch JA, Hanson CA, Immunophenotypic aberrancy in adult acute lymphoblastic leukemia.Am J Clin Pathol 1990;94(5):590-9
5. Faber J, Kantarjian H, Roberts MW, Keating M, Freireich E, Albitar M, Terminal deoxynucleotidyl Transferase-negative acute lymphoblastic leukemia.Arch Pathol Lab Med 2000;124(1):92-7